Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Adv Protein Chem Struct Biol. 2016 Dec 9;107:117–154. doi: 10.1016/bs.apcsb.2016.11.002

Fig. 1.

Fig. 1

Canonical (left) and alternative (right) NF-κB pathway and the target strategies: (1) inhibition of cell-surface receptor binding, (2) inhibition of receptor adaptor proteins, (3) IKK inhibition, (4) blocking IκB degradation/upregulating IκB /inhibiting proteasome, (5) inhibit nuclear translocation, and (6) block DNA binding/transcriptional activation.